|
|
||||||||
Ann Thorac Surg 1998;65:496-502
© 1998 The Society of Thoracic Surgeons
Section of Thoracic and Cardiovascular Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA
Dr Elkins, Thoracic Surgery, University of Oklahoma Health Sciences Center, PO Box 26901, Oklahoma City, OK 73190.
Presented at the Thirty-third Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Feb 35, 1997.
| Abstract |
|---|
|
|
|---|
Methods. The records of 150 consecutive patients, aged 7 days to 21 years (median age, 12 years, 75% less than 15 years) were reviewed. Follow-up was complete within the last 12 months (median, 2.8 years; range, 1 month to 10 years). Echocardiographic assessment was available on 116 (71%) within 1 year of closure and in 136 (91%) within 2 years.
Results. Survival was 97.3% at 8 years. Late autograft valve dysfunction required replacement in 2 and reoperation with restitution of autograft function in 6. Freedom from reoperation for autograft dysfunction is 90% ± 4% at 8 years. Freedom from reoperation for homograft obstruction is 94% ± 3% at 8 years. Pulmonary homograft dysfunction (gradient >40 mm Hg) was present in 4 additional patients. Freedom from reoperation on the homograft or a gradient of 40 mm Hg is 89% ± 4% at 8 years. All patients have a normal, active lifestyle, without anticoagulants for their aortic valve replacement.
Conclusions. The Ross operation is the preferred operative replacement in children requiring aortic valve replacement.
| Introduction |
|---|
|
|
|---|
Acceptance of these tenets by cardiologists and cardiac surgeons has been slow due to the technical demands of this aortic valve operation and the inherent need for reconstruction of the right ventricular outflow tract, thereby placing two valves at risk. During the past 10 years, increasing numbers of cardiac surgeons have used the Ross operation in children and young adults, demonstrating that the technical aspects of the operative procedure can be learned and the operative mortality is low [2] [3] [4]. Enlargement of the pulmonary autograft, as a valve replacement and as a root replacement, that is proportional to somatic growth of the patient has been demonstrated [5].
As additional surgeons have become experienced with the Ross operation, it has been identified as the operation of choice for children and young adults who require aortic valve operation. The indications for the Ross operation have expanded and the operative techniques have been modified. To assess the impact of some of these expanded indications and modifications of technique and to provide additional long-term follow-up of the Ross operation in children, especially those with a root replacement, we conducted the present review.
| Patients and Methods |
|---|
|
|
|---|
All patients had preoperative transthoracic echocardiography, and for the past 6 years these findings have been confirmed with transesophageal echocardiography at the time of operation. In 56 patients a preoperative cardiac catheterization was accomplished when the patients preoperative diagnosis indicated the need for catheterization and angiography.
Surgical Technique
The surgical technique for pulmonary autograft replacement of the aortic valve has been described previously [6]. The early operative procedures included 20 in which the pulmonary autograft valve replacement was done as a scalloped subcoronary implant, the most common technique used by Ross group [7]. Thirty-two patients had their autograft valve inserted as an inclusion cylinder and 98 had a root replacement of their aortic root. The implantation technique was selected based on the age of the patient, size of the aortic annulus, dysplasia of the aortic annulus, and presence of subvalvar obstruction or dysplasia. More recently the root replacement has become the most commonly used operative technique. The effect of age on implantation technique is shown in Fig 1.
|
|
Homograft reconstruction of the right ventricular outflow tract was accomplished with a cryopreserved pulmonary homograft in 149 patients and with a cryopreserved aortic homograft in 1. In most patients, including the very young, it was possible to use an adult-sized homograft (Fig 2).
|
Valve-related mortality and morbidity were categorized according to the guidelines of Edmunds and associates [11].
Statistical Analysis
All analyses were performed using SAS System software, version 6.10 (SAS Institute, Cary, NC). Between-group differences of continuous variables were analyzed using analysis of variance methods, and
2 or Fishers exact methods were used to test differences between proportions. Patient survival analysis and actuarial estimates of freedom from postoperative events were accomplished using Kaplan-Meier methods. Survival curves are displayed to the point in time where the standard error of the estimate exceeds 10% unless otherwise noted. Differences between survival distributions were assessed by log-rank and Wilcoxon testing, and p values less than 0.05 were considered significant for all tests.
Cox proportional hazards multivariable regression was used for investigating variables associated with (1) development of 2+ aortic insufficiency or reoperation on the autograft valve and (2) development of a 40 mm Hg or greater gradient or reoperation on the homograft valve. A forward stepwise selection method was used to add variables to the model, requiring significance at p less than 0.05 for entry and retention in the model. Variables considered for the autograft valve outcomes model were age, sex, diagnosis of aortic stenosis, previous aortic valve operation, year of operation, thoracic aortic aneurysm, type 1 VSD, history of bacterial endocarditis, and insertion technique (root replacement, inclusion cylinder, or scalloped subcoronary). Variables analyzed for association with homograft outcomes were age, sex, previous cardiac operation, year of operation, history of bacterial endocarditis, and size of homograft.
| Results |
|---|
|
|
|---|
Early postoperative morbidity occurred in 5 patients. Two required reexploration for bleeding: 1 from a homograft suture line and 1 from an autograft root replacement suture line. Three patients required permanent pacemakers for complete heart block: 1 with a unicusp aortic valve and severe aortic annulus dysplasia, 1 requiring aortic annulus reduction, and 1 requiring replacement of a prosthetic aortic valve.
Eight patients have required reoperation of the autograft valve for insufficiency. Progressive autograft insufficiency developed in 1 patient, and by 2 months after his Ross operation and replacement of an 8-cm ascending aortic aneurysm, increasing aortic annulus dilatation had developed. At reoperation, the aortic annulus was reduced in size from 26 mm to 20 mm with restoration of normal autograft function. A second patient required early autograft reoperation (7 months), which required replacement of the scalloped subcoronary implant. This was the second patient in this series, and this failure was thought to be due to the early learning curve. Six patients required reoperation for autograft insufficiency more than 1 year after their Ross operation. One required replacement as a leaflet had prolapsed and become adherent to a VSD patch used to close a subarterial VSD. The remaining 5 have had successful treatment of their autograft valve insufficiency, with annular reduction in 5 and reduction and fixation of the sinotubular dimension in 2 [9]. Of the 146 survivors, 144 (98.6%) continue to retain the benefits of their autograft valve. One patient required reoperation for recurrence of subvalvar stenosis treated by resection and left ventricular myectomy. Actuarial freedom from reoperation for autograft insufficiency or recurrent left ventricular obstruction was 90% ± 4% at 8 years (Fig 3).
|
|
Valve-Related Complications
Reoperation on the autograft valve, development of increasing autograft insufficiency, development of pulmonary homograft obstruction, or reoperation on the pulmonary homograft have been the only valve-related complications in the 146 surviving patients. The actuarial freedom from all valve-related complications is 72% ± 6% at 8 years.
Multivariate Analysis
The results of Cox proportional hazards regression are shown in Table 1Table 2. Table 1 shows the analysis for the end point defined as the need for reoperation on the autograft valve or development of 2+ autograft insufficiency on two or more consecutive echocardiographic evaluations. Univariate (ie, unadjusted for other factors) analysis indicated that previous aortic valve operation, preoperative diagnosis of aortic stenosis, and later year of operation decreased the likelihood of reoperation for autograft insufficiency or the development of 2+ aortic insufficiency. The presence of an ascending aortic aneurysm or type 1 VSD increased the risk of these autograft complications. Multivariate analysis identified previous aortic valve operation and later year of operation as protective and ascending aortic aneurysm as a risk for autograft complications.
|
|
| Comment |
|---|
|
|
|---|
One patient-related factor that also requires modification of the Ross operation is the presence of a subarterial infundibular ventricular septal defect. This defect was associated with an increased risk of early failure by univariate analysis (p < 0.01). Three of 7 patients with subarterial VSD required reoperation or had development of 2+ autograft insufficiency. Those patients with a subarterial VSD who have had stable autograft function have had fixation of the autograft annulus at the time of autograft root replacement or have had closure of the VSD with the anterior wall of the right ventricle as described for closure of the ventriculotomy when performing an aortoventriculoplasty [14].
Previous multivariate analysis for autograft valve failure of all patients having a Ross operation at our institutions demonstrated that a previous aortic valve operation was protective [9]. Further analysis of those data demonstrated that this was due to the preoperative diagnosis of aortic stenosis and that patients with a bicuspid aortic valve and aortic insufficiency as their preoperative diagnosis were more likely to have autograft valve failure. This was again confirmed in this subset of patients, ie, 21 years of age or less. The benefit of later year of operation is thought to be related to the "learning curve," the more widespread use of the autograft root replacement, and adoption of techniques to reduce the size of the aortic annulus and "fix" the size of the aortic annulus where appropriate. Long-term data on some of these modifications or additions to the Ross operation are not available, but present results are very encouraging.
Pulmonary autograft root replacement was used in 95 of the patients (65%), and the length of follow-up on the use of this technique now extends to 10 years. The initiation of this technique for the Ross operation is similar in our experience [16] and the experience reported by Gerosa and associates [17]. In a multivariate analysis previously reported, this technique was associated with a decreased frequency of reoperation on the autograft valve or the development of 2+ autograft valve insufficiency [9]. Although in the children this multivariate association was not statistically significant, it is encouraging that for the available period of follow-up outcome appears to be at least equal to that reported for the scalloped subcoronary technique. Long-term data (>20 years) are available for the scalloped subcoronary technique, with a reported freedom from reoperation of 85% at 20 years [7].
The present series is of particular interest as 99% of the surviving patients continue to maintain the benefits as described by Ross group of their pulmonary autograft valve. The incidence of failure of the pulmonary homograft valve (94% at 8 years) has been gratifyingly low, and reoperation has not been difficult. Using a very rigid definition of valve-related complications, the freedom from all valve-related complications is 77% at 8 years. There are no comparable series of patients with prosthetic aortic valves reported. Limited experiences with the newer prosthetic aortic valves in children have been reported with a low operative mortality and an 8- to 10-year survival of 80% to 100% in three different series [18] [19] [20]. In young children with a small annulus, annular enlargement with a Konno-Rastan, Manouguian, or Nicks procedure to allow placement of an adult-sized valve has been recommended [19]. Anticoagulation has been used in most patients; aspirin and dipyridamole are suggested as adequate in patients who are in sinus rhythm, but some authors recommend the use of warfarin anticoagulation [19]. Continued follow-up of patients with prosthetic aortic valves, aortic annular enlargement, and anticoagulant therapy will identify whether they have a reduced incidence of valve-related complications and late death as compared with the results that appear to be obtainable with the Ross operation.
The Ross operation in children appears to have an operative risk that is low and to provide a lifestyle that is unencumbered by anticoagulants. The valve-related complications are not life-threatening, and the most serious risk, that of reoperation, appears to be small. Long-term satisfactory autograft valve function can be achieved. We continue to recommend the Ross operation as the procedure of choice in children who require aortic valve replacement.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Horer, T. Hanke, U. Stierle, J. J.M. Takkenberg, A. J.J.C. Bogers, W. Hemmer, J. G. Rein, R. Hetzer, M. Hubler, D. R. Robinson, et al. Neoaortic root diameters and aortic regurgitation in children after the ross operation. Ann. Thorac. Surg., August 1, 2009; 88(2): 594 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ozaslan, T. Wittlinger, N. Monsefi, T. Bouhmidi, S. Theres, M. Doss, G. Wimmer-Greinecker, and A. Moritz Long-term follow-up of supra-annular pulmonary autograft aortic root replacement in patients with bicuspid aortic valve Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 583 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Stewart, C. L. Backer, N. D. Hillman, C. Lundt, and C. Mavroudis The Ross Operation in Children: Effects of Aortic Annuloplasty Ann. Thorac. Surg., October 1, 2007; 84(4): 1326 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. McMullan, G. Oppido, B. Davies, Y. Kawahira, A. D. Cochrane, Y. d'Udekem d'Acoz, D. J. Penny, and C. P. Brizard Surgical strategy for the bicuspid aortic valve: Tricuspidization with cusp extension versus pulmonary autograft J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 90 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chiappini, B. Absil, J. Rubay, P. Noirhomme, J.-C. Funken, R. Verhelst, A. Poncelet, and G. El Khoury The Ross Procedure: Clinical and Echocardiographic Follow-Up in 219 Consecutive Patients Ann. Thorac. Surg., April 1, 2007; 83(4): 1285 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Berdajs, G. Zund, U. Schurr, C. Camenisch, M. I. Turina, and M. Genoni Geometric models of the aortic and pulmonary roots: suggestions for the Ross procedure Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 31 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Brown, M. Ruzmetov, P. Vijay, M. D. Rodefeld, and M. W. Turrentine The ross-konno procedure in children: outcomes, autograft and allograft function, and reoperations. Ann. Thorac. Surg., October 1, 2006; 82(4): 1301 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doss, J. P. Wood, S. Martens, G. Wimmer-Greinecker, and A. Moritz Do Pulmonary Autografts Provide Better Outcomes Than Mechanical Valves? A Prospective Randomized Trial Ann. Thorac. Surg., December 1, 2005; 80(6): 2194 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Luciani, A. Favaro, G. Casali, F. Santini, and A. Mazzucco Ross Operation in the Young: A Ten-Year Experience Ann. Thorac. Surg., December 1, 2005; 80(6): 2271 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Acar Invited commentary Ann. Thorac. Surg., August 1, 2005; 80(2): 494 - 494. [Full Text] [PDF] |
||||
![]() |
J. Odim, H. Laks, V. Allada, J. Child, S. Wilson, and D. Gjertson Results of Aortic Valve-Sparing and Restoration With Autologous Pericardial Leaflet Extensions in Congenital Heart Disease Ann. Thorac. Surg., August 1, 2005; 80(2): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G Raja and M. Pozzi Growth of Pulmonary Autograft After Ross Operation in Pediatric Patients Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 285 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Alphonso, M. Baghai, K. Dhital, G. Mood, R. Tulloh, C. Austin, and D. Anderson Midterm results of the Ross procedure Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tiete, J. S. Sachweh, U. Roemer, R. Kozlik-Feldmann, B. Reichart, and S. H. Daebritz Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution Ann. Thorac. Surg., June 1, 2004; 77(6): 2151 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hraska, M. Krajci, Ch. Haun, K. Ntalakoura, V. Razek, F. Lacour-Gayet, J. Weil, and H. Reichenspurner Ross and Ross-Konno procedure in children and adolescents: mid-term results Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 742 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Bohm, C. A. Botha, W. Hemmer, C. Starck, G. Blumenstock, D. Roser, and J.-G. Rein Older patients fare better with the Ross operation Ann. Thorac. Surg., March 1, 2003; 75(3): 796 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Pigula, J. Paolillo, M. McGrath, S. K. Gandhi, J. L. Myers, B. Rebovich, and R. D. Siewers Aortopulmonary size discrepancy is not a contraindication to the pediatric Ross operation Ann. Thorac. Surg., November 1, 2001; 72(5): 1610 - 1614. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmidtke, M. Bechtel, M. Hueppe, and H.-H. Sievers Time Course of Aortic Valve Function and Root Dimensions After Subcoronary Ross Procedure for Bicuspid Versus Tricuspid Aortic Valve Disease Circulation, September 18, 2001; 104 (2009): I-21 - I-24. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Ohye, C. A. Gomez, B. J. Ohye, C. S. Goldberg, and E. L. Bove The Ross/Konno procedure in neonates and infants: intermediate-term survival and autograft function Ann. Thorac. Surg., September 1, 2001; 72(3): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, Q. Chen, S. M. Langley, A. P. Salmon, B. R. Keeton, M. P. Haw, and J. L. Monro Is there still a place for open surgical valvotomy in the management of aortic stenosis in children? The view from Southampton Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 239 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laudito, M. M. Brook, S. Suleman, M. S. Bleiweis, L. D. Thompson, F. L. Hanley, and V. M. Reddy The Ross procedure in children and young adults: A word of caution J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bacha, G. M. Satou, A. M. Moran, D. Zurakowski, G. R. Marx, J. F. Keane, and R. A. Jonas Valve-sparing operation for balloon-induced aortic regurgitation in congenital aortic stenosis J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 162 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, A. McDonald, S. M. Langley, M. J.R. Dalrymple-Hay, M. P. Haw, and J. L. Monro Aortic valve replacement in children: are mechanical prostheses a good option? Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 125 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, A. Omran, J. Ivanov, S. Armstrong, M. P.L. de Sa, B. Sonnenberg, and G. Webb DILATION OF THE PULMONARY AUTOGRAFT AFTER THE ROSS PROCEDURE J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 210 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Solymar, G. Sudow, and D. Holmgren INCREASE IN SIZE OF THE PULMONARY AUTOGRAFT AFTER THE ROSS OPERATION IN CHILDREN: GROWTH OR DILATION? J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 4 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis, C. L. Backer, C. E. Duffy, E. Pahl, and D. F. Wax Pediatric coronary artery bypass for Kawasaki, congenital, post arterial switch, and iatrogenic lesions Ann. Thorac. Surg., August 1, 1999; 68(2): 506 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Lupinetti, B. W. Duncan, A. M. Scifres, C. T. Fearneyhough, K. Kilian, G. L. Rosenthal, F. Cecchin, T. K. Jones, and S. P. Herndon Intermediate-term results in pediatric aortic valve replacement Ann. Thorac. Surg., August 1, 1999; 68(2): 521 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mavroudis, M. Gevitz, W. S. Ring, C. L. McIntosh, and M. Schwartz The Society of Thoracic Surgeons national congenital heart surgery database report: : Analysis of the first harvest (1994-1997) Ann. Thorac. Surg., August 1, 1999; 68(2): 601 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niwaya, C. J. Knott-Craig, K. Santangelo, M. M. Lane, K. Chandrasekaran, and R. C. Elkins Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis Ann. Thorac. Surg., June 1, 1999; 67(6): 1603 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Kouchoukos Aortic allografts and pulmonary autografts for replacement of the aortic valve and aortic root Ann. Thorac. Surg., June 1, 1999; 67(6): 1846 - 1848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rubay, M. Buche, G. A. El Khoury, J.-L. J. Vanoverschelde, T. Sluysmans, B. Marchandise, J.-C. Schoevaerdts, and R. A. Dion The Ross operation: mid-term results Ann. Thorac. Surg., May 1, 1999; 67(5): 1355 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Roughneen, S. Y. DeLeon, B. W. Eidem, N. J. Thomas, F. Cetta, D. A. Vitullo, K. E. Magliato, T. E. Berry, and M. Bakhos Semilunar valve switch procedure: autotransplantation of the native aortic valve to the pulmonary position in the ross procedure Ann. Thorac. Surg., March 1, 1999; 67(3): 745 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niwaya, C. J. Knott-Craig, M. M. Lane, K. Chandrasekaren, E. D. Overholt, and R. C. Elkins CRYOPRESERVED HOMOGRAFT VALVES IN THE PULMONARY POSITION: RISK ANALYSIS FOR INTERMEDIATE-TERM FAILURE J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 141 - 147. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |